The Safety and Immunological Effects of rAd5-EBV-LMP2 Vaccine in Nasopharyngeal Carcinoma Patients: A Phase I Clinical Trial and Two-Year Follow-Up
published in: Chemical & Pharmaceutical Bulletin
date of publication: 2016-01-01
language: English
main subject: phase I clinical trial
Cites articles
There is nothing here
Article - wd:Q42048989